These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR; N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717 [TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD. Rymer J; Anand SS; Sebastian Debus E; Haskell LP; Hess CN; Jones WS; Muehlhofer E; Berkowitz SD; Bauersachs RM; Bonaca MP; Patel MR Circulation; 2023 Dec; 148(24):1919-1928. PubMed ID: 37850397 [TBL] [Abstract][Full Text] [Related]
13. Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. Berger JS; Katona BG; Jones WS; Patel MR; Norgren L; Baumgartner I; Blomster J; Mahaffey KW; Held P; Millegård M; Heizer G; Reist C; Fowkes FG; Hiatt WR Am Heart J; 2016 May; 175():86-93. PubMed ID: 27179727 [TBL] [Abstract][Full Text] [Related]
14. Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. Samsky MD; Hellkamp A; Hiatt WR; Fowkes FGR; Baumgartner I; Berger JS; Katona BG; Mahaffey KW; Norgren L; Blomster JI; Rockhold FW; DeVore AD; Patel MR; Jones WS J Am Heart Assoc; 2021 Jun; 10(12):e018684. PubMed ID: 34056910 [TBL] [Abstract][Full Text] [Related]
15. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease. Jones WS; Baumgartner I; Hiatt WR; Heizer G; Conte MS; White CJ; Berger JS; Held P; Katona BG; Mahaffey KW; Norgren L; Blomster J; Millegård M; Reist C; Patel MR; Fowkes FG; Circulation; 2017 Jan; 135(3):241-250. PubMed ID: 27840336 [TBL] [Abstract][Full Text] [Related]
16. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health. Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK; J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138 [TBL] [Abstract][Full Text] [Related]
17. Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention. Xi Z; Zhou Y; Zhao Y; Liu X; Liang J; Chai M; Yu Y; Liu W Cardiovasc Drugs Ther; 2020 Apr; 34(2):179-188. PubMed ID: 32140798 [TBL] [Abstract][Full Text] [Related]
18. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355 [TBL] [Abstract][Full Text] [Related]
19. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial. Park DW; Kwon O; Jang JS; Yun SC; Park H; Kang DY; Ahn JM; Lee PH; Lee SW; Park SW; Choi SW; Lee SG; Yoon HJ; Ahn T; Kim MH; Nah DY; Lee SY; Chae JK; Park SJ; Circulation; 2019 Dec; 140(23):1865-1877. PubMed ID: 31553203 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. Low Wang CC; Blomster JI; Heizer G; Berger JS; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Lopes RD; Olin JW; Rockhold FW; Mahaffey KW; Patel MR; Hiatt WR; J Am Coll Cardiol; 2018 Dec; 72(25):3274-3284. PubMed ID: 30573030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]